Institutional investors purchased a net $13.9 thousand shares of EXAS during the quarter ended December 2013. This may signal that the smart money is gaining interest in this company as the 89.74% of shares outstanding that institutional investors hold is actually below the Biotechnology industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
RIEDWEG & HROVAT AG Bought 35.0 Thousand shares of Exact Sciences Corp
MAZAMA CAPITAL MANAGEMENT, INC. Sold 2.9 Thousand shares of Exact Sciences Corp
THOMPSON INVESTMENT MANAGEMENT, ... Sold 6.2 Thousand shares of Exact Sciences Corp